Abstract. The aim of the present study was to investigate the interactions among messenger RNAs (mRNAs), microRNAs (miRNAs), and long noncoding RNAs (lncRNAs) in colorectal cancer (CRC), in order to examine its underlying mechanisms. The raw gene expression data was downloaded from the Gene Expression Omnibus (GEO) database. An online tool, GEO2R, which is based on the limma package, was used to identify differentially expressed genes. The co-expression between lncRNAs and mRNAs was identified utilizing the weighted gene co-expression analysis package of R to construct a coding non-coding (CNC) network. The function of the genes in the CNC network was determined by performing Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathways enrichment analysis. The interactions among miRNAs, mRNAs and lncRNAs were predicted using Lncbase and mirWalk to construct the competing endogenous RNA (ceRNA) network. The expression of the genes involved in the ceRNA network was further validated in The Cancer Genome Atlas dataset. A total of 3,183 dysregulated mRNAs, 78 dysregulated miRNAs and 2,248 dysregulated lncRNAs were screened in two GEO datasets. Combined with the results of the dysregulated genes, 169 genes were selected to construct the CNC network. 'p53 signaling pathway' and the 'cell cycle' were the most significant enriched pathways in the genes involved in the CNC network. Finally, a validated ceRNA network composed of 2 lncRNAs (MIR22HG and RP11-61I13.3), 5 miRNAs (hsa-miR-765, hsa-miR-198, hsa-miR-125a-3p, hsa-miR-149-3p and hsa-miR-650) and 5 mRNAs (ANK2, BTK, GBP2, PCSK5 and PDK4) was obtained. In conclusion, MIR22HG may regulate PCSK5, BTK and PDK4, and RP11-61I13.3 may regulate the ANK2, GBP2, PCSK5 through sponging miRNAs to act on the progression of CRC, and the potential function of these genes have been revealed. However, the diagnostic and prognostic value of these genes requires further validation.
Introduction
Colorectal cancer (CRC) is one of the most frequently diagnosed cancers of the digestive system. It was estimated that there would be 97,220 new cases and 50,630 CRC-related deaths in the United States in 2018 (1) . Much of the rising burden is attributable to population growth and aging, as well as sociodemographic changes. Recurrence is the major cause of CRC-related death (2) .
Despite the diagnosis and treatment of CRC, the survival of the patient is closely associated to the stage of the tumor at diagnosis, and 40-50% of patient mortality is due to distant metastasis (3, 4) . Considering the enormous threat of CRC to human health, new diagnostic and therapeutic approaches are required for early cancer detection and effective treatment (5) .
In order to find a more effective treatment for CRC, a more thorough understanding of its pathogenesis is important. Previously, there has been increasing evidence that microRNAs (miRNAs) are functional in cancer progression by downregulating their targets, including mRNA, long non-coding RNA (lncRNA), circular RNA and pseudogenes (6) (7) (8) . Nevertheless,
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overexpression of these targets could abolish the downregulatory effect of miRNA in turn (9) (10) (11) . Moreover, more than one miRNA target could compete with miRNAs as competing endogenous RNA (ceRNA) and overexpression of one ceRNA could indirectly upregulate other ceRNAs (12, 13) .
ceRNA crosstalk was first proposed by Poliseno et al (14) . Phosphatase and tensin homolog pseudogene 1 (PTENP1) could upregulate PTEN by sponging their common miRNAs. It was subsequently confirmed that various genes could participate in the development of cancer through ceRNA mechanisms (15) . In breast cancer, overexpression of NEAT1 induced by BRCA1-deficiency can silence hsa-miR-129-5p and upregulate WNT4, a target of hsa-miR-129-5p, which leads to activation of oncogenic WNT signaling (16) . Liang et al (17) reported that the oncogenic functions of lncRNA H19 in CRC may be attributed to its ceRNA activity to sequester miR-138 and miR-200a and therefore, upregulate the expression levels of VIM, ZEB1 and ZEB2, the critical genes involved in epithelial mesenchymal transition. With the development of gene sequencing technology, it has been shown that the expression of various lncRNAs is either upregulated or downregulated in CRC tissues to regulate several signaling pathways, such as the Wnt, p13K/Akt and Ras pathways, through ceRNA crosstalk (18, 19) . Therefore, it has been proven that ceRNA crosstalk is a critical mechanism for the complex pathogenesis and multi-step development of CRC, which may be a potential starting point for the development of novel CRC treatment methods, which deserves further study. The aim of the present study, was to identify a ceRNA network between non-coding RNAs and coding genes in CRC and to reveal the potential mechanism of CRC progression, which may aid in establishing a novel clinical CRC treatment system.
Materials and methods

Gene datasets and clinical information.
Raw gene expression data of the GSE109454 (20) and GSE41655 (https://www. ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE41655) datasets were downloaded from the National Center of Biotechnology Information Gene Expression Omnibus (GEO) database (https://www.ncbi.nlm.nih.gov/gds/). In the GSE109454 dataset, tumor samples and adjacent non-tumor samples were obtained from 6 patients with CRC. Clinical information of these CRC patients from the original study is shown in (22) .
Identification of differentially expressed genes (DEGs).
GEO2R (http://www.ncbi.nlm.nih.gov/geo/geo2r/) is an online tool provided by GEO. GEO2R is based on the R language limma package (v3.26.8) (23) . GEO2R was used to screen DEGs between tumor and normal samples in the GSE41655 and GSE109454 datasets. At the same time, using false discovery rate correction, multiple t-tests were used to determine the statistical significance of the DEGs. |log 2 fold change (FC)|>1 and a P-value <0.05 were set as the cut-off criteria. Subsequently, probes without a corresponding gene symbol were filtered.
Weighted gene co-repression analysis (WGCNA).
To screen significant co-expression modules, WGCNA was performed as previously described (24, 25) . Probe sets were first filtered based on the variance of expression value across all samples. Probe sets with repeating gene symbols were also removed based on the expression variance. The R package WGCNA (v1.61) (26) was used to construct the co-expression networks. Independent signed networks were constructed from the CRC samples and normal samples. The adjacency matrix was constructed using a soft threshold power of 12 to make the soft threshold >0.8. Network interconnectedness was measured by calculating the topology overlap using the TOMdist function with a signed TOM-Type. The average hierarchical clustering was performed to group the genes based on the topological overlap dissimilarity measure (1-TOM) of their connection strengths. The network modules were identified using a dynamic tree cut algorithm, with a minimum cluster size of 30 and a merge threshold function of 0.25. Genes that were not assigned to particular modules were designated as grey. The module that had the strongest association with CRC was selected for further analysis and the co-expression in this module was filtered as follows: i) The weight score of co-expression >0.3; ii) only the coding and non-coding co-expression relationships were retained; iii) only the genes that were differentially expressed were retained; and iv) only the genes in one pair that had the same expression tendency were retained.
Gene function analysis.
To determine the function of the selected genes in CRC, Gene Ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis for the genes in the co-expression network were implemented using DAVID (v6.8; https://david. ncifcrf.gov/). In the present study, pathway and process enrichment analysis was performed using the following ontological sources: GO Biological Processes (BPs) and KEGG Pathway. All genes in the H. sapiens genome were used as background in the enrichment analysis. The P-value was calculated based Male  69  Adenocarcinoma  T2N0M0  Male  63  Adenocarcinoma  T4N1M1  Male  64  Adenocarcinoma  T3N1M0  Female  75  Adenocarcinoma  T1N0M0  Male  49  Adenocarcinoma  T3N1M0  Female  70  Adenocarcinoma  T3N1M0  Male  80  Adenocarcinoma  T1N0M0  Male  65  Adenocarcinoma  T2N0M0  Male  56  Adenocarcinoma  T3N0M0  Female  76  Adenocarcinoma  T2N1M0  Male  56  Adenocarcinoma  T1N0M0  Female  68  Adenocarcinoma  T2N1M0  Male  74  Adenocarcinoma  T4N1M0  Male  61  Adenocarcinoma  T4N1M0  Male  70  Adenocarcinoma  T3N1M0  Female  80  Adenocarcinoma  T1N0M0  Male  71  Adenocarcinoma  T2N0M0  Male  35  Adenocarcinoma  T3N0M0  Male  59  Adenocarcinoma  T3N0M0  Male  60  Adenocarcinoma  T3N0M0  Female  68  Adenocarcinoma  T2N0M0  Male  61  Adenocarcinoma  T3N1M0  Male  51  Adenocarcinoma  T3N1M0  Male  55  Adenocarcinoma  T4N2M1  Male  66  Adenocarcinoma  T3N1M0  Male  72  Adenocarcinoma  T4N2M0 on accumulative hypergeometric distribution, and the q-value was calculated using the Benjamini-Hochberg program to consider multiple tests (27) . When hierarchical clustering was performed on enriched terms, the κ score was used as a measure of similarity, and sub-trees with similarity >0.3 were then treated as clusters.
Prediction of the lncRNA-miRNA interactions and miRNA-mRNA interactions. The interactions between differentially expressed miRNAs (DEMs) and DEGs were predicted using miRWalk v3.0 (http://mirwalk.umm.uni-heidelberg. de/), which integrated the predictions of miRDB (28) and TargetScan (29) . A score ≥0.95 was considered as the critical criterion for miRWalk predictive analysis. Considering the inhibition effect of miRNA on mRNA expression, the interactions of miRNA and mRNA with the same expression tendency were deleted. The interactions between miRNA and lncRNA were predicted using DIANA-LncBase v2.0 (30), and the score ≥0.4 was considered to be the cut-off criterion for predictive analysis in the LncBase prediction module. After the predicted targets were intersected with DEGs in the GSE109454 dataset and DEMs in the GSE41655 dataset, the mRNAs, miRNAs and lncRNAs were selected to construct the lncRNA-mRNA-miRNA regulatory network. The cytoscape software (v3.40; https://cytoscape.org/) was used to visualize the network.
Validation in the cancer genome atlas (TCGA) datasets.
TCGA is a public platform for researchers to download and assess free datasets (https://cancergenome.nih.gov/) (31). RNA-sequencing (RNA-seq) data and clinical data from 31 cancer types are included in TCGA. In the present study, to improve the reliability of the analysis, the expression of hub genes was validated in TCGA datasets using an easy-use online tool GEPIA (v1.0; http://gepia.cancer-pku.cn/). The tumor type was limited to colon adenocarcinoma (COAD). Finally, RNA-seq data and clinical data from 275 primary tumor samples of COAD and 349 corresponding normal samples in TCGA datasets were used. Box and whisker plots were used to display the expression of the genes involved in the ceRNA network. |log 2 FC|>1 and P-value <0.05 were set as the cut-off criteria to determine the differential expression between primary tumor samples and normal samples.
Results
Identification of DEGs.
DEGs in the GSE109454 dataset and DEMs in the GSE41655 dataset were screened with a threshold of P<0.05 and |log 2 FC|>1. As shown in Fig. 1 , a total of 2,599 downregulated genes (1,430 mRNAs and 1,169 lncRNAs) and 2,832 upregulated genes (1,753 mRNAs and 1,079 lncRNAs) were screened in the GSE109454 dataset. In the GSE41655 dataset, a total of 116 DEMs, including 71 downregulated miRNAs and 45 upregulated miRNAs, between colorectal adenoma samples and normal colorectal samples, were screened ( Fig. 2A and C) , and a total of 109 DEMs, including 55 downregulated miRNAs and 54 upregulated miRNAs, between colorectal adenocarcinoma samples and normal colorectal samples, were screened ( Fig. 2B and D) . After the DEMs in the two groups were intersected, 78 DEMs were selected for further analysis.
Construction of co-expression network.
Using the R package for WGCNA, 39 modules were generated (Fig. 3A) and all of the uncorrelated genes were assigned to the grey module. The number of the genes in every module is shown in Table III . The trait of the samples in the present study was divided into tumor and non-tumor. Out of 39 modules, the blue module was most positively associated with CRC (r=0.98; P=1x10 -8 ; Fig. 3B ). A total of 2,556,690 co-expression relationships in the blue module were therefore further filtered, and 169 genes (86 mRNAs and 83 lncRNAs) and 245 relationships were selected to construct the CNC network (Fig. 4) .
GO and KEGG pathway enrichment analysis of genes in the CNC network.
GO and KEGG enrichment analysis was performed for the genes in the blue module and the result is shown in Table IV . 'p53 signaling pathway' and 'cell cycle' were the most significantly enriched pathways in the KEGG pathway enrichment analysis. 'Cell division', 'chromosome segregation' and 'mitotic nuclear division' were the top 3 enriched BP terms.
Construction and validation of ceRNA network.
To identify how lncRNAs regulate mRNAs through miRNAs in the CNC network, online prediction tools were used to determine miRNA-lncRNA and miRNA-mRNA interactions. The predicted miRNAs were then intersected with DEMs identified in the GSE41655 dataset. Subsequently a ceRNA network was constructed, which was composed of 24 mRNAs, 16 miRNAs and 10 lncRNAs (Fig. 5) . To improve the reliability of the analysis, the expression of genes involved in the ceRNA network was validated in TCGA datasets. The results showed that 3 lncRNAs (MIR22HG, CHL1-AS2 and RP11-61I13.3) were downregulated in TCGA datasets (Fig. 6) . As shown in Fig. 7, ANK2 , BTK, FGL2, GBP2, PCSK5 and PDK4 were downregulated, and ARMC10, CENPF, CENPF, DKC1, GINS4, PAICS, PARPBP, RAD54B, RAE1 and TOMM34 were upregulated in TCGA datasets. Subsequently, these validated mRNAs and lncRNAs were selected to construct a ceRNA network. Finally, a validated ceRNA network composed of 2 lncRNAs (MIR22HG and RP11-61I13.3), 5 miRNAs (hsa-miR-765, hsa-miR-198, hsa-miR-125a-3p, hsa-miR-149-3p and hsa-miR-650) and 5 mRNAs (ANK2, Female  63  Adenocarcinoma  T1N0M0  Male  63  Adenocarcinoma  T1N0M0  Male  69  Adenocarcinoma  T4N1M0  Female  69  Adenocarcinoma  T2N0M0  Male  61  Adenocarcinoma  T4N1M0  Male  45  Adenocarcinoma  T2N0M0 pTNM, pathological Tumor-Node-Metastasis. BTK, GBP2, PCSK5 and PDK4) was obtained (Fig. 8) . PCSK5 was at the center of the validated ceRNA network, and interacted with 4 miRNAs.
Discussion
In developing countries, the incidence of CRC is rapidly increasing. CRC is the fifth most common malignant tumor after lung, liver, esophagus and breast cancer in China (32) . Statistically, there were 376,300 new cases and 191,000 CRC-related deaths in China in 2015 (32) . Therefore, CRC has become a public health issue and it is essential to understand the etiological factors and mechanisms of CRC progression to improve prevention and survival rates.
In the present study, 3,183 dysregulated mRNAs, 78 dysregulated miRNAs and 2,248 dysregulated lncRNAs were screened in two GEO datasets. WGCNA analysis was conducted to identify the co-expression between coding genes and non-coding genes. Combined with the dysregulated genes, 169 genes were selected to construct the CNC network. GO and KEGG pathway enrichment analysis was performed to identify the biological function of the genes in the CNC network. The genes in the CNC network were significantly enriched in 'cell cycle' and 'p53 signaling pathway'. DEMs identified from the GS41655 dataset were predicted to be involved in miRNA-lncRNA and miRNA-mRNA interactions were used to construct the ceRNA network. The expression of 3 lncRNAs (MIR22HG, CHL1-AS2 and RP11-61I13.3) and 15 mRNAs (ANK2, ARMC10, BTK, CENPF, DKC1, FGL2, GBP2, GINS4, PAICS, PARPBP, PCSK5, PDK4, RAD54B, RAE1 and TOMM34) in the ceRNA network were validated and found to be dysregulated in TCGA datasets.
PCSK5 is at the center of the validated ceRNA network, and interacts with 4 miRNAs. PCSK5 belongs to the subtilisin-like proprotein convertase family. The members of this family are proprotein convertases that process a potential precursor protein into its biologically active product (33) . Reports of the involvement of PCSK5 in cancer are rare. In triple-negative breast cancer (TNBC), a lack of PCSK5 could lead to the bioactivity of growth differentiation factor (GDF11) as a tumor-suppressor. PCSK5 reconstitution mobilizes the latent TNBC reservoir of GDF11 in vitro and inhibits TNBC metastasis to the lung of syngeneic hosts (34) . However, the function of PCSK5 in CRC is largely unknown. The present study indicated that PCSK5 could be regulated by MIR22HG through miR-198 and miR-149-3p, and regulated by RP11-61I13.3 through miR-765 and miR-125-3p.
MIR22HG has been identified as a tumor suppressor in several studies. In hepatocellular carcinoma (HCC), MIR22HG expression is significantly downregulated, and can regulate the expression of high mobility group box 1 and its downstream pathways by deriving miR-22-3p to suppress HCC cell proliferation, invasion and metastasis (35) . In endometrial cancer (EC), MIR22HG can act as sponge of miR-141-3p, which could inhibit EC cells proliferation and induce EC cells apoptosis by targeting death-associated protein kinase 1 (36) . In addition, the present study suggested that MIR22HG could regulate the expression of BTK and PDK4 through miR-650. Therefore, MIR22HG might be an important regulator in CRC. BTK is a new regulator of p53 and BTK induction, which leads to p53 phosphorylation. Inhibiting BTK can reduce p53-dependent senescence and apoptosis (37) . In CRC, miR-650 is a direct regulator of N-myc downstream-regulated gene 2, which is a potential tumor suppressor gene (38) . Therefore, MIR22HG might be an important regulator in CRC.
RP11-61I13.3 is a novel lncRNA and little is known about its function. RP11-61I13.3 can also regulate GBP2 and ANK2 through miR-765, and miR-765 has been demonstrated to be an onco-miRNA in HCC (39) and oral squamous cancer (40) . Meanwhile, GBP2 has been associated with a better prognosis in several cancer types, including breast cancer and ovarian cancer (41, 42) .
In conclusion, two lncRNAs (MIR22HG and RP11-61I13.3) have been identified that can regulate several mRNAs through sponging miRNAs in CRC, and the potential functions of these genes have been revealed. The ceRNA network involved in PCSK5 has been shown to play an important role in CRC. However, the diagnostic and prognostic value of these genes still requires further validation.
